Biosimilar Clinical Development
Redigert av Kerry B. Barker, PhD, Bo Jin, Sandeep M. Menon, Siyan Xu, Sr., Ralph B. D'Agostino, 2020.Del av serien Chapman & Hall/CRC Biostatistics Series.
Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
Språk: Engelsk
Ikke tilgjengelig for Klikk&Hent
Midlertidig tomt på lager
Bestillingsvare. Forventes sendt om ca 10 dager
Biosimilar Clinical Development
Redigert av Kerry B. Barker, PhD, Bo Jin, Sandeep M. Menon, Siyan Xu, Sr., Ralph B. D'Agostino, 2020.Del av serien Chapman & Hall/CRC Biostatistics Series.
Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
Språk: Engelsk
Ikke tilgjengelig for Klikk&Hent
Midlertidig tomt på lager
Bestillingsvare. Forventes sendt om ca 10 dager
Ved å fullføre kjøpet aksepterer du kjøpsvilkårene.
